StockDriftsStockDriftsIldong Pharmaceutical (249420) has 5 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩39M ($27K) in reported transaction value. The earliest filing StockDrifts holds for Ildong Pharmaceutical is dated 2024-03-22; the most recent is 2026-04-02. Across these filings the average return since disclosure is +89.80%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | BUY | Market Buy | 조노제 jonoje | Managing Director | 30 | ₩27,000 | +4.7% | ₩810K ($563) |
| 2026-04-01 | BUY | Market Buy | 조노제 jonoje | Managing Director | 50 | ₩29,350 | -3.7% | ₩1M ($1K) |
| 2026-03-31 | BUY | Market Buy | 조노제 jonoje | Managing Director | 50 | ₩28,050 | +0.8% | ₩1M ($974) |
| 2025-07-01 | BUY | 신규선임 | 서승욱 Seo Seung-wook | Managing Director | 605 | ₩12,660 | +200.9% | ₩8M ($5K) |
| 2025-02-24 | BUY | Market Buy | 최규환 Gyu-hwan Choi | Internal director | 1.0K | ₩11,800 | +222.9% | ₩12M ($8K) |
| 2024-12-24 | BUY | Market Buy | 이승현 Seunghyun Lee | Managing Director | 2.0K | ₩11,750 | +224.3% | ₩24M ($16K) |
| 2024-03-22 | BUY | 신규보고 | 최규환 Gyu-hwan Choi | Internal director | 5.0K | ₩16,870 | +125.8% | ₩84M ($59K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.